In vitro uptake and stability study of pVEC and its all-D analog

Biological Chemistry

Volumn 384, Issue 3, 2003, Pages 387-393

  Elmquist, Anna ^a   Langel, Ülo ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

All D analog; Carrier; Cell penetrating peptide; Degradation; Endothelial cells; VE Cadherin

Indexed keywords

BUFFER; CADHERIN; CARBOXYPEPTIDASE A; CARBOXYPEPTIDASE B; DRUG CARRIER; LYSINE; PEPTIDE DERIVATIVE; PHOSPHATE; TRYPSIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; AORTA; CARBOXY TERMINAL SEQUENCE; CELL TRANSPORT; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; DRUG STABILITY; DRUG UPTAKE; ENDOCYTOSIS; ENDOTHELIUM CELL; ENZYMATIC DEGRADATION; FIBROBLAST; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SERUM; STRUCTURE ACTIVITY RELATION;

ANIMALS; AORTA; CARRIER PROTEINS; CELL LINE; CELL MEMBRANE PERMEABILITY; DRUG CARRIERS; DRUG STABILITY; ENDOPEPTIDASES; ENDOTHELIUM, VASCULAR; FIBROBLASTS; FLUORESCENT DYES; HUMANS; MICE; PEPTIDE FRAGMENTS; PEPTIDES; STEREOISOMERISM;

ANIMALIA; MURINAE;

EID: 0038743278     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.044     Document Type: Review

References (21)

1. Bernkop-Schnürch, A. (1998). The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J. Controlled Release 52, 1-16.
2. Chorev, M., Shavitz, R., Goodman, M., Minick, S. and Guillemin, R. (1979). Partially modified retro-inverso-enkephalinamides: topochemical long-acting analogs in vitro and in vivo. Science 204, 1210-1212.
3. Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G. and Prochiantz, A. (1996). Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271, 18188-18193.
4. Elmquist, A., Lindgren, M., Bartfai, T. and Langel, Ü. (2001). VE-cadherin derived cell-penetrating peptide, pVEC, with carrier functions. Exp. Cell Res. 269, 237-244.
5. Fish, K.N., Söderberg-Naucler, C., Mills, L.K., Stenglein, S. and Nelson, J.A. (1998). Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol. 72, 5661-5668.
6. Fix, J.A. (1996). Oral controlled release technology for peptides: status and future prospects. Pharm. Res. 13, 1760-1764.
7. Garner, P., Sherry, B., Moilanen, S. and Huang, Y. (2001). In vitro stability of α-helical peptide nucleic acids (αPNAs). Bioorg. Med. Chem. Lett. 11, 2315-2317.
8. INK4A fusion protein to human diploid fibroblasts. FEBS Lett. 427, 203-208.
9. Lindgren, M., Hällbrink, M., Prochiantz, A. and Langel, Ü. (2000). Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99-103.
10. Marks, N., Kastin, A.J., Stern, F. and Coy, D.H. (1978). Metabolism of potent enkephalin analogs (FK 33-824, D-Ala2, penta-fluorophenylalanine-4-enkephalinamide and a dimer of D-Ala2-enkephalin) and D-amino acid substituted derivatives of human β-endorphin. Brain Res. Bull. 3, 687-690.
11. Mukherjee, S., Ghosh, R.N. and Maxfield, F.R. (1997). Endocytosis. Phys. Rev. 77, 759-803.
12. Pooga, M., Soomets, U., Hällbrink, M., Valkna, A., Saar, K., Rezai, K., Kahl, U., Hao, J-X., Xu, X.J., Wiesenfeld-Hallin, Z., Hökfelt, T., Bartfai, T. and Langel, Ü. (1998). Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nature Biotechnol. 16, 857-861.
13. Pooga, M., Kut, C., Kihlmark, M., Hällbrink, M., Fernaeus, S., Raid, R., Land, T., Hallberg, E., Bartfai, T. and Langel, Ü. (2001). Cellular translocation of proteins by transportan. FASEB J. 15, 1451-1453.
14. Rothbard, J.B., Garlington, S., Lin, Q., Kirschberg, T., Kreider, E., McGrane, P.L., Wender, P.A. and Khavari, P.A. (2000). Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nature Med. 6, 1253-1257.
15. Rouselle, C., Clair, P., Lefauconnier, J.M., Kaczorek, M., Scherrmann, J.M. and Temsamani, J. (2000). New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol. Pharmacol. 57, 679-686.
16. Schwarze, S.R, Ho, A., Vocero-Akbani, A. and Dowdy, S.F. (1999). In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572.
17. Stein, S., Weiss, A., Adermann, K., Lazarovici, P., Hochman, J. and Wellhöner, H. (1999). A disulfide conjugate between anti-tetanus antibodies and HIV (37-72) Tat neutralize tetanus toxin inside chromaffin cells. FEBS Lett. 458, 383-386.
18. Tung, C-H. and Weissleder, R. (2002). Cell-penetrating peptide conjugations and magnetic cell labels. In: Cell-Penetrating Peptides, Ü. Langel, ed. (Boca Raton, USA: CRC Press), pp. 327-346.
19. Udenfriend, S., Stein, S., Bohlen, P., Dairman, W., Leimgruber, W. and Weigele, M. (1972). Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178, 871-872.
20. Wade, D., Boman, A., Wåhlin, B., Drain, C.M., Andreu, D., Boman, H.G. and Merrifield, R.B. (1990). All-D amino acid-containing channel forming antibiotic peptides. Proc. Natl. Acad. Sci. USA 87, 4761-4765.
21. Wender, P.A., Mitchell, D.J., Pattabiraman, K., Pelkey, E.T., Steinman, L. and Rothbard, J.B. (2000). The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. USA 97, 13003-13008.